Drug FDA Class III Ongoing Failed specifications
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30
Alembic Pharmaceuticals Limited Published Jan 14, 2026
Risk level
Class IIIUnlikely to cause harm, but violates labeling or manufacturing rules.
Severity score 40/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Alembic Pharmaceuticals Limited or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
Hazards
Diester Impurity · primary
Affected products (1)
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30
FESOTERODINE FUMARATE
NDC: 62332-175, 62332-176, 62332-175-30, 62332-175-90, 62332-175-91, 62332-175-10, 62332-176-30, 62332-176-90, 62332-176-91, 62332-176-10, 2405003360
Lot codes: 2405003360
Code info: Lot# 2405003360, Exp Date: Jan 31, 2026
Affected areas
Nationwide
Timeline
- InitiatedDec 16, 2025
- PublishedJan 14, 2026
- Recall number
- D-0248-2026
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.